Tuesday, December 23, 2025

Tag: rare disease

Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook

Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q3 CY2025 results topping the market’s revenue expectations...

GLP-1 goliath updates demand for top weight loss drug

Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss...